Rankings
▼
Calendar
ANIK Q4 2025 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$31M
+2473.3% YoY
Gross Profit
$19M
62.6% margin
Operating Income
$646,000
2.1% margin
Net Income
$292,000
1.0% margin
EPS (Diluted)
$0.02
QoQ Revenue Growth
+10.1%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$190M
Total Liabilities
$47M
Stockholders' Equity
$143M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
-$1M
+2473.3%
Gross Profit
$19M
$23M
-15.0%
Operating Income
$646,000
$28M
-97.7%
Net Income
$292,000
-$22M
+101.3%
Geographic Segments
UNITED STATES
$18M
75%
Europe
$6M
25%
← FY 2025
All Quarters